Crescita Therapeutics Inc. Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita's board of directors and management team have demonstrated success in building Crescita's predecessor company, Nuvo Research Inc., including developing multiple drugs that are now approved and commercialized and negotiating multiple licensing transactions. For additional information, please visit www.crescitatherapeutics.com.

Contact Information:
Investor Relations, Email: ir@crescitatx.com

Latest

May 15, 2019, 08:30 ET Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

LAVAL, QC, May 15, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare...


May 15, 2019, 07:30 ET Crescita Therapeutics Reports 2019 First Quarter Results

Year-over-Year Revenue Growth of 16.4% Positive Adjusted EBITDA for Third Consecutive Quarter And Generates $2.3 Million in Cash LAVAL, QC, May 15, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX)...


May 07, 2019, 08:00 ET Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

LAVAL, QC, May 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare ...


Apr 25, 2019, 09:17 ET Crescita Therapeutics Signs Pliaglis® Out-Licensing Agreement with Cantabria Labs for €2.5M Upfront After Reacquiring Rest-of-World Rights

LAVAL, QC, April 25, 2019 /CNW Telbec/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX and OTC US: CRRTF), a Canadian commercial dermatology company with a portfolio of...


Apr 17, 2019, 07:30 ET Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto

LAVAL, QC, April 17, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology company, is pleased to announce that its President ...


Mar 21, 2019, 08:36 ET Crescita Therapeutics Reports Fourth Quarter and Fiscal 2018 Results Record Annual Revenue of $16.6M and Adjusted EBITDA of $1.5M Strong Royalties

LAVAL, QC, March 21, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug ...


Feb 04, 2019, 07:00 ET Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra's Dermatology Product

LAVAL, QC, and ORLEANS, ON, Feb. 4, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita") (TSX: CTX), a Canadian commercial dermatology company and Tetra Natural Health (NHP), a subsidiary of Tetra...


Dec 17, 2018, 07:30 ET U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®

LAVAL, QC, Dec. 17, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and...


Nov 09, 2018, 07:30 ET Crescita Therapeutics™ Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive

LAVAL, QC, Nov. 9, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug...


Nov 08, 2018, 07:30 ET Crescita Reinvigorates Skincare Line Leveraging its MMPE™ Technology and Becomes One of the First Companies Worldwide to Release Anti-Ageing

LAVAL, QC, Nov. 8, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and...


Oct 15, 2018, 07:30 ET Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol

LAVAL, QC, Oct. 15, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare products and...


Aug 10, 2018, 07:30 ET Crescita Therapeutics™ Reports 2018 Second Quarter Results

Continues to Improve Cash Utilization LAVAL, QC, Aug. 10, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of...


Jun 13, 2018, 17:50 ET Crescita Therapeutics™ Announces Director Election Results of its Annual General Meeting

LAVAL, QC, June 13, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug...


May 09, 2018, 07:30 ET Crescita Therapeutics™ Reports 2018 First Quarter Results

Revenue up 75% Positive EBITDA1 LAVAL, QC, May 9, 2018 /CNW Telbec/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of...


Apr 26, 2018, 07:30 ET Crescita Therapeutics™ To Present at the 2018 Bloom Burton &Co. Healthcare Investor Conference in Toronto

LAVAL, QC, April 26, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), Canadian commercial dermatology company, is pleased to announce that its President and CEO, Serge...


Apr 05, 2018, 07:30 ET Crescita Therapeutics Inc. Adds Recognized Skincare Expert to its Leadership Team

MISSISSAUGA, ON, April 5, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or the "Company"), a commercial dermatology company with a portfolio of non-prescription skincare products and ...


Apr 03, 2018, 07:30 ET Crescita Therapeutics™ Announces the Appointment of Serge Verreault as President & CEO

MISSISSAUGA, ON, April 3, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or the "Company"), a commercial dermatology company with a portfolio of non-prescription skincare products and ...


Mar 29, 2018, 07:30 ET Crescita Announces Launch of Pliaglis in U.S.

MISSISSAUGA, ON, March 29, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) ("Crescita" or "the Company"), a commercial dermatology company with a portfolio of non-prescription skincare products...


Mar 28, 2018, 07:30 ET Crescita Therapeutics™ Reports 2017 Fourth Quarter and Year End Results

MISSISSAUGA, ON, March 28, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and...


Mar 12, 2018, 07:30 ET Crescita Therapeutics Inc. Announces Completion of Oversubscribed Rights Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Rights Offering oversubscribed by 39% MISSISSAUGA, ON, March 12, 2018 /CNW/ - Crescita Therapeutics ...


Jan 31, 2018, 08:30 ET Crescita Therapeutics Inc. Announces Rights Offering to Raise Up To $3.7 Million

Commitments for $2,060,000 Obtained from Knight Therapeutics, Funds Advised by Bloom Burton & Co., Management and Board Members Crescita Announces Growth Initiatives for 2018 /NOT FOR DISTRIBUTION TO ...


Nov 10, 2017, 08:00 ET Crescita Therapeutics™ Announces 2017 Third Quarter Results and Appoints New CFO

MISSISSAUGA, ON, Nov. 10, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX:CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare products and...


Sep 18, 2017, 07:30 ET Crescita Therapeutics™ Reports Positive Topline Results of Phase 2 Clinical Trial for the Treatment of Plaque Psoriasis

MISSISSAUGA, ON, Sept. 18, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a Canadian commercial dermatology company with a portfolio of non-prescription skincare...


Aug 29, 2017, 07:30 ET Crescita Therapeutics™ Announces Completion of $1.0 million Convertible Debenture Financing with Bloom Burton Funds

MISSISSAUGA, ON, Aug. 29, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX:CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare products and...


Aug 14, 2017, 22:01 ET Crescita Therapeutics™ Announces Profitable 2017 Second Quarter Results

MISSISSAUGA, ON, Aug. 14, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX:CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare products and...